Compare · RDUS vs STE
RDUS vs STE
Side-by-side comparison of Radius Recycling Inc. (RDUS) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- RDUS operates in Consumer Discretionary, while STE operates in Health Care - the two are in different parts of the market.
- STE is the larger of the two at $20.50B, about 61.0x RDUS ($336.1M).
- Over the past year, RDUS is up 1.3% and STE is down 13.5% - RDUS leads by 14.8 points.
- STE has hit the wire 39 times in the past 4 weeks while RDUS has been quiet.
- RDUS has more recent analyst coverage (18 ratings vs 16 for STE).
- Company
- Radius Recycling Inc.
- STERIS plc (Ireland)
- Price
- $30.00+0.02%
- $210.04-1.01%
- Market cap
- $336.1M
- $20.50B
- 1M return
- +1.32%
- -1.87%
- 1Y return
- +1.32%
- -13.48%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 0
- 39
- Recent ratings
- 18
- 16
Radius Recycling Inc.
Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine and other therapeutics. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a short-wear-time transdermal patch that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone receptor-positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts.
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest RDUS
- SEC Form 15-12G filed by Radius Recycling Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Radius Recycling Inc.
- Director Hunter Rhonda D returned $1,357,619 worth of shares to the company (45,254 units at $30.00), closing all direct ownership in the company (SEC Form 4)
- Chairman, President & CEO Lundgren Tamara L. returned $38,365,800 worth of shares to the company (1,278,860 units at $30.00), closing all direct ownership in the company (SEC Form 4)
- SVP, CFO Gaggini Stefano R. returned $2,708,430 worth of shares to the company (90,281 units at $30.00), closing all direct ownership in the company (SEC Form 4)
- SVP, Chief HR Officer Erich Wilson D returned $1,785,900 worth of shares to the company (59,530 units at $30.00), closing all direct ownership in the company (SEC Form 4)
- EVP & COO Hathhorn Marc E. returned $4,367,430 worth of shares to the company (145,581 units at $30.00), closing all direct ownership in the company (SEC Form 4)
- SVP & President, Recycling P&S Heiskell Steven returned $4,174,800 worth of shares to the company (139,160 units at $30.00), closing all direct ownership in the company (SEC Form 4)
- Director Friedman Gregory R returned $562,186 worth of shares to the company (18,740 units at $30.00), closing all direct ownership in the company (SEC Form 4)
- Director Shoemaker Leslie L returned $600,507 worth of shares to the company (20,017 units at $30.00), closing all direct ownership in the company (SEC Form 4)
Latest STE
- Sr. VP, Gen Counsel, and Sec. Zangerle John Adam covered exercise/tax liability with 401 units of Ordinary Shares, decreasing direct ownership by 1% to 36,678 units (SEC Form 4)
- V.P. & Corporate Treasurer Tamaro Renato covered exercise/tax liability with 65 units of Ordinary Shares, decreasing direct ownership by 1% to 6,194 units (SEC Form 4)
- Sr. VP and GM, Life Sciences Madsen Julia covered exercise/tax liability with 195 units of Ordinary Shares, decreasing direct ownership by 2% to 12,257 units (SEC Form 4)
- SVP & GM, AST Kohler Kenneth E covered exercise/tax liability with 150 units of Ordinary Shares, decreasing direct ownership by 1% to 11,332 units (SEC Form 4)
- SVP & Chief HRO Fraser Mary Clare covered exercise/tax liability with 600 units of Ordinary Shares, decreasing direct ownership by 4% to 13,716 units (SEC Form 4)
- President and CEO Carestio Daniel A covered exercise/tax liability with 1,889 units of Ordinary Shares and sold $946,799 worth of Ordinary Shares (4,428 units at $213.82), decreasing direct ownership by 9% to 63,647 units (SEC Form 4)
- Sr. Vice Pres., CFO Burton Karen L covered exercise/tax liability with 90 units of Ordinary Shares, decreasing direct ownership by 0.68% to 13,184 units (SEC Form 4)
- Sr. VP, Gen Counsel, and Sec. Zangerle John Adam covered exercise/tax liability with 365 units of Ordinary Shares, decreasing direct ownership by 0.97% to 37,079 units (SEC Form 4)
- V.P. & Corporate Treasurer Tamaro Renato covered exercise/tax liability with 64 units of Ordinary Shares, decreasing direct ownership by 1% to 6,259 units (SEC Form 4)
- Sr. VP and GM, Life Sciences Madsen Julia covered exercise/tax liability with 239 units of Ordinary Shares, decreasing direct ownership by 2% to 12,452 units (SEC Form 4)